SCHEMBL6986758

SCHEMBL6986758

O=S(=O)(Nc1ccc2c(c1)CCCN2)c1ccc(F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 4/20 0.56
LMNA P02545 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
KDM4E B2RXH2 1/20 0.56
KMT2A Q03164 1/20 0.56
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
CA12 O43570 1/20 0.53
CA9 Q16790 1/20 0.53
ESR1 P03372 1/20 0.51
MAPT P10636 2/20 0.51
TP53 P04637 1/20 0.51
ALDH1A1 P00352 2/20 0.50
THRB P10828 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
RORC P51449 1/20 0.49
BRD4 O60885 1/20 0.47
POLB P06746 2/20 0.47
HSD17B3 P37058 1/20 0.47
HSD17B2 P37059 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985107 0.87 LMNA (0.67) PKMLMNASMN1; SMN2CA1CA2
SCHEMBL6985319 0.87 CA12 (0.53) PKMLMNASMN1; SMN2CA1CA2
SCHEMBL6982218 0.87 PKM (0.56) PKMLMNASMN1; SMN2KMT2ACA1
SCHEMBL6984820 0.87 HTR6 (0.61) PKMLMNASMN1; SMN2KDM4EKMT2A
SCHEMBL31681377 0.85 EIF2AK2 (0.54) PKMLMNASMN1; SMN2CA1CA2
SCHEMBL5871138 0.82 SMN1; SMN2 (0.69) PKMLMNASMN1; SMN2KDM4EKMT2A
SCHEMBL6976538 0.81 PKM (0.65) PKMLMNASMN1; SMN2KMT2ACA1
SCHEMBL2283294 0.80 CA1 (0.60) PKMKMT2ACA1CA2CA12
SCHEMBL6983859 0.79 PKM (0.56) PKMLMNAMAPTTP53BRD4
SCHEMBL4537369 0.79 TP53 (0.50) PKMLMNASMN1; SMN2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed